Literature DB >> 2420787

Human esophageal carcinoma cells have fewer, but higher affinity epidermal growth factor receptors.

S P Banks-Schlegel, J Quintero.   

Abstract

Squamous cell carcinomas have recently been shown to contain increased numbers of epidermal growth factor (EGF) receptors. Since EGF has an important role in epithelial growth and differentiation, it is possible that modulation of its receptor may have an important role in neoplasia. In an attempt to further explore the relationship of EGF receptor expression to malignant transformation, we examined 14 squamous cell carcinoma cell lines of the esophagus for the number and affinity of EGF receptors. Seven cell lines were newly isolated by this laboratory and recently characterized. The seven additional cell lines were obtained from Japan (4 cell lines) and South Africa (3 cell lines). Surprisingly, we found that esophageal carcinomas contained lowered quantities of surface EGF receptors (2- to 100-fold) and that the affinity of the EGF receptor was increased (6- to 100-fold) when compared to normal esophageal epithelial cells. Moreover, the biologic response of esophageal carcinoma cells to EGF differed markedly from that of other squamous cell tumor cells exhibiting elevated numbers of receptors, such as A431 and SCC-15. Human esophageal carcinoma cells were maximally stimulated by the addition of 5 ng/ml of EGF, similar to normal esophageal keratinocytes, but in contrast to normal cells were not inhibited by the higher concentrations tested (up to 40 ng/ml). On the other hand, addition of any EGF to the medium (beyond that normally present in serum) was found to dramatically inhibit the growth of A431 and SCC-15 cells. Our findings indicate that squamous cell neoplasia is not dependent upon increased numbers of cell surface EGF receptors, that EGF receptor number may have a determinant role in EGF cell toxicity, and that the stimulatory response of cells to EGF may reflect a complex function of EGF receptor number, affinity, and occupancy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420787

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.

Authors:  C R Carlin; D Simon; J Mattison; B B Knowles
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Role of salivary and seric epidermal growth factor in pathogenesis of reflux esophagitis in chronic alcoholics and nondrinkers.

Authors:  R Benamouzig; F Ferrière; C Guettier; J Amouroux; T Coste; J Rautureau
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

3.  Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.

Authors:  J C Reubi; U Horisberger; W Lang; J W Koper; R Braakman; S W Lamberts
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Cloning and characterization of a bovine genomic fragment homologous to epidermal growth factor genes.

Authors:  S J John; B F Benkel; S Bilodeau-Goeseels
Journal:  Can J Vet Res       Date:  2004-10       Impact factor: 1.310

5.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.

Authors:  M H Werner; P A Humphrey; D D Bigner; S H Bigner
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Systemic treatment with recombinant human epidermal growth factor accelerates healing of sclerotherapy-induced esophageal ulcers and prevents esophageal stricture formations in pigs.

Authors:  C O Juhl; L Vinter-Jensen; L S Jensen; E Nexø; J C Djurhuus; E Z Dajani
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

7.  Recombinant human epidermal growth factor prevents sclerotherapy-induced esophageal ulcer and stricture formations in pigs.

Authors:  C O Juhl; L S Jensen; T Steiniche; E Moussa
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

8.  Effects of orally administered epidermal growth factor on enteropathogenic Escherichia coli infection in rabbits.

Authors:  A Buret; M E Olson; D G Gall; J A Hardin
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

9.  Molecular and cellular features of esophageal cancer cells.

Authors:  T Nishihira; Y Hashimoto; M Katayama; S Mori; T Kuroki
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour.

Authors:  S Q Maddy; G D Chisholm; A Busuttil; F K Habib
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.